NCT04247984 2022-03-11
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
ChineseAMS
Phase 2 Completed
Clinical Trials
3 trialsNCT02295774 2018-11-05
Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA
CosmoTech
Phase 2 Completed
NCT01694966 2017-11-06
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
CosmoTech
Phase 3 Completed